[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 954 Introduced in House (IH)]

<DOC>






117th CONGRESS
  2d Session
H. RES. 954

  Expressing support for designation of March 3, 2022, as ``National 
                  Triple-Negative Breast Cancer Day''.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 28, 2022

 Mr. Morelle submitted the following resolution; which was referred to 
                 the Committee on Oversight and Reform

_______________________________________________________________________

                               RESOLUTION


 
  Expressing support for designation of March 3, 2022, as ``National 
                  Triple-Negative Breast Cancer Day''.

Whereas triple-negative breast cancer was recognized as a distinct type of 
        cancer in 2006;
Whereas triple-negative breast cancer disproportionately affects young women, 
        Black and Hispanic women, and those with BRCA gene mutations;
Whereas triple-negative breast cancers are estrogen receptor-negative, 
        progesterone receptor-negative, and HER2-negative, making them distinct 
        from other breast cancers;
Whereas there is no targeted therapy for triple-negative breast cancers;
Whereas 10 to 20 percent of all breast cancer diagnoses are designated as 
        triple-negative;
Whereas triple-negative breast cancer can be more aggressive and more likely to 
        spread and recur;
Whereas triple-negative breast cancer accounts for around 25 percent of all 
        deaths from breast cancer in the United States; and
Whereas March 3, 2022, would be an appropriate date to designate as ``National 
        Triple-Negative Breast Cancer Day'': Now, therefore, be it
    Resolved, That the House of Representatives supports the 
designation of ``National Triple-Negative Breast Cancer Day'' to create 
awareness of the devastating effect of these cancers on families in the 
United States and the need for strong action to eradicate triple-
negative breast cancer.
                                 <all>